Recombinant human monoclonal antibody expressed in CHO binding to human tumor antigen CTAA16.88. Technetium (99mTc) votumumab is a human monoclonal antibody labelled with theradionuclide technetium-99m and was developed for the detection of colorectal tumors.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human CTAA16.88 Recombinant Antibody (Votumumab)Recombinant monoclonal antibody to CTAA16.88. Votumumab is a human monoclonal antibody labelled with the radionuclide technetium-99m. It can be potentially used in the treatment of Colorectal tumors.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2514-VHH | Recombinant Anti-Human CTAA16.88 VHH Single Domain Antibody | WB, IP, ChiP, Neut, ELISA | Llama VHH |
There are currently no Customer reviews or questions for TAB-715. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.